Ainsworth Sean 4
4 · Ocuphire Pharma, Inc. · Filed Nov 25, 2020
Insider Transaction Report
Form 4
Ainsworth Sean
Director
Transactions
- Purchase
Series A Warrant (right to buy)
2020-11-19+13,394→ 13,394 totalExercise: $4.48From: 2020-11-19Exp: 2025-11-19→ Common Stock (13,394 underlying) - Purchase
Common Stock
2020-11-19+8,865→ 44,665 total - Purchase
Series B Warrant (right to buy)
2020-11-19+1,574→ 1,574 totalExercise: $0.00From: 2020-11-19Exp: 2022-01-28→ Common Stock (1,574 underlying)
Footnotes (2)
- [F1]The Reporting Person purchased shares, Series A Warrants and Series B Warrants as part of a private placement for an aggregate price of $50,000.
- [F2]Subject to adjustment based on certain price reset provisions.